Long-term irreversible trastuzumab-induced cardiotoxicity for metastatic breast cancer in a patient without cardiac risk factors

Trastuzumab improves clinical outcomes in patients with human epidermal growth factor receptor-2-positive breast cancer. However, cardiotoxicity is a potentially important concern, and the long-term cardiac effects of trastuzumab therapy remain unclear. Although reduction of cardiac function by tras...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Satoru, Ikari, Ayana, Nitta, Toshikatsu, Horiuchi, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499211/
https://www.ncbi.nlm.nih.gov/pubmed/28694974
http://dx.doi.org/10.1093/omcr/omx038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499211/
https://www.ncbi.nlm.nih.gov/pubmed/28694974
http://dx.doi.org/10.1093/omcr/omx038

Ejemplares similares